For example, a clinical study evaluated 42 patients with CRPS-Type I and 34 healthy controls and found that systemic anti-inflammatory IL-4 and IL-10 mRNA and protein levels were reduced in patients with CRPS. This evidence concerns the gene IL4 and complex regional pain syndrome.